Evaluating Use Characteristics for the Oncotype Dx 21-Gene Recurrence Score and Concordance With Chemotherapy Use in Early-Stage Breast Cancer
Author:
Affiliation:
1. McKesson Specialty Health, The Woodlands; Texas Oncology, Austin, TX; and Rocky Mountain Cancer Center, Greenwood Village, CO
Abstract
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Health Policy,Oncology (nursing),Oncology
Link
http://ascopubs.org/doi/pdfdirect/10.1200/JOP.2012.000638
Reference29 articles.
1. Prospective Multicenter Study of the Impact of the 21-Gene Recurrence Score Assay on Medical Oncologist and Patient Adjuvant Breast Cancer Treatment Selection
2. 2000 Update of Recommendations for the Use of Tumor Markers in Breast and Colorectal Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology*
3. National Institutes of Health Consensus Development Conference Statement: Adjuvant Therapy for Breast Cancer, November 1-3, 2000
4. Meeting Highlights: Updated International Expert Consensus on the Primary Therapy of Early Breast Cancer
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Young Age as a Predictor of Chemotherapy Recommendation and Treatment in Breast Cancer: A National Cancer Database Study;Journal of Surgical Research;2024-04
2. A simplified risk scoring system for predicting high-risk groups in gene expression tests for patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative, and node-positive breast cancer;Annals of Surgical Treatment and Research;2023
3. Impact of genomic assays on treatment and outcomes in locally advanced breast cancer;Breast Cancer Research and Treatment;2022-05-30
4. The impact of age and nodal status on variations in oncotype DX testing and adjuvant treatment;npj Breast Cancer;2022-03-01
5. Circulating Cell-Free DNA in Breast Cancer: Searching for Hidden Information towards Precision Medicine;Cancers;2021-02-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3